PVR and viral infectious disease: Cluster 5 is related to immune tolerance to viral infections, and its subclusters 5–14 are related to TIGIT and CD155, which are considered to be the third molecules [32] for immune checkpoints following PD-1/PDL-1 and CTLA4/CD80/86, whose inhibitors have already been used in pharmaceuticals.